UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 392

Sortiert nach

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

Journal of clinical oncology, 2021-11, Vol.39 (31), p.3441-3452

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia

British journal of haematology, 2017-02, Vol.176 (4), p.618-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis

Diagnostics (Basel), 2024-03, Vol.14 (6), p.658

2024

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia With 17p Deletion: A Retrospective European Group for Blood and Marrow Transplantation Analysis

Journal of clinical oncology, 2008-11, Vol.26 (31), p.5094-5100

2008

Link zum Volltext

Verfügbarkeit prüfen

Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion

Leukemia & lymphoma, 2017-04, Vol.58 (4), p.859-865

2017

Link zum Volltext

Verfügbarkeit prüfen

Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation

Clinical cancer research, 2010-09, Vol.16 (17), p.4382-4391

2010

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow‐up of dose‐adjusted EPOCH plus rituximab (DA‐EPOCH‐R) in untreated patients with poor prognosis large B‐cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group

British journal of haematology, 2015-04, Vol.169 (2), p.188-198

2015

Link zum Volltext

Verfügbarkeit prüfen

MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by α4β1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration

Blood, 2006-11, Vol.108 (9), p.3143-3151

2006

Link zum Volltext

Verfügbarkeit prüfen

Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration

Blood, 2008-01, Vol.111 (1), p.383-386

2008

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma

Cancer, 2009-05, Vol.115 (9), p.1892-1898

2009

Link zum Volltext

Verfügbarkeit prüfen

VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase–9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration

Blood, 2010-01, Vol.115 (4), p.846-849

2010

Link zum Volltext

Verfügbarkeit prüfen

Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells

Frontiers in immunology, 2016-10, Vol.7, p.454-454

2016

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q− and 17p−)

Clinical cancer research, 2005-11, Vol.11 (21), p.7757-7763

2005

Link zum Volltext

Verfügbarkeit prüfen

The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

American journal of hematology, 2023-12, Vol.98 (12), p.1856-1868

2023

Link zum Volltext

Verfügbarkeit prüfen

Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study

Leukemia & lymphoma, 2023-04, Vol.64 (5), p.913-926

2023

Link zum Volltext

Verfügbarkeit prüfen

Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor

Haematologica (Roma), 2006-05, Vol.91 (5), p.640-648

2006

Link zum Volltext

Verfügbarkeit prüfen

Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain

Cancer cell, 2010-02, Vol.17 (2), p.160-172

2010

Link zum Volltext

Verfügbarkeit prüfen

TCL1A expression delineates biological and clinical variability in B-cell lymphoma

Modern pathology, 2009-02, Vol.22 (2), p.206-215

2009

Link zum Volltext

Verfügbarkeit prüfen

New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing

PloS one, 2012-06, Vol.7 (6), p.e38158-e38158

2012

Link zum Volltext

Verfügbarkeit prüfen

Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide

PloS one, 2014-06, Vol.9 (6), p.e99993

2014

Link zum Volltext

Verfügbarkeit prüfen

HLA‐partially matched cellular therapy (stem‐cell microtransplantation) for acute myeloid leukaemia: description of four cases

British journal of haematology, 2014-05, Vol.165 (4), p.580-581

2014

Link zum Volltext

Verfügbarkeit prüfen

Arsenic trioxide synergistically potentiates the cytotoxic effect of fludarabine in chronic lymphocytic leukemia cells by further inactivating the Akt and ERK signaling pathways

Biochemical and biophysical research communications, 2015-05, Vol.461 (2), p.243-248

2015

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of progelatinase B/proMMP‐9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen

Journal of leukocyte biology, 2014-08, Vol.96 (2), p.185-199

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 392

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(369)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Life Sciences & Biomedicine
(124)
Humans
(105)
Male
(74)
Female
(67)
Middle Aged
(56)
Aged
(50)
Adult
(42)
Hematology
(40)
Chronic Lymphocytic Leukemia
(34)
Oncology
(33)
Aged, 80 And Over
(30)
Technology
(30)
Biological And Medical Sciences
(23)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(22)
Medical Sciences
(22)
Leukemia
(21)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(19)
Leukemia, Lymphocytic, Chronic, B-Cell - Pathology
(19)
Physical Sciences
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia

Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis

Allogeneic Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia With 17p Deletion: A Retrospective European Group for Blood and Marrow Transplantation Analysis

Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion

Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation

Long‐term follow‐up of dose‐adjusted EPOCH plus rituximab (DA‐EPOCH‐R) in untreated patients with poor prognosis large B‐cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group

MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by α4β1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration

Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration

Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma

VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase–9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration

Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells

Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q− and 17p−)

The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study

Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor

Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain

Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

TCL1A expression delineates biological and clinical variability in B-cell lymphoma

New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing

Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide

HLA‐partially matched cellular therapy (stem‐cell microtransplantation) for acute myeloid leukaemia: description of four cases

Arsenic trioxide synergistically potentiates the cytotoxic effect of fludarabine in chronic lymphocytic leukemia cells by further inactivating the Akt and ERK signaling pathways

Overexpression of progelatinase B/proMMP‐9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

Suchergebnisse filtern